Neratinib after adjuvant chemotherapy and trastuzumab in HER2-positive early breast cancer: Primary analysis at 2 years of a phase 3, randomized, placebo-controlled trial (ExteNET).
Küçük Resim Yok
Tarih
2015
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Amer Soc Clinical Oncology
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Açıklama
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer -- MAY 29-JUN 02, 2015 -- Chicago, IL
Anahtar Kelimeler
Kaynak
Journal of Clinical Oncology
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
33
Sayı
15
